sublingual immunotherapy dust mite
Selected indexed studies
- Sublingual immunotherapy of house dust mite respiratory allergy in China. (Allergol Immunopathol (Madr), 2019) [PMID:29921463]
- House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma. (Ann Pharmacother, 2018) [PMID:29642713]
- Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy. (Allergy Asthma Proc, 2021) [PMID:33404387]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Sublingual immunotherapy of house dust mite respiratory allergy in China. (2019) pubmed
- House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma. (2018) pubmed
- Efficacy of sublingual immunotherapy tablets in dust mite and pollen allergy. (2021) pubmed
- House dust mite sublingual immunotherapy in allergic rhinitis. (2018) pubmed
- Revolutionizing Allergy Care: Sublingual Immunotherapy for House Dust Mite Allergy. (2025) pubmed
- Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis. (2015) pubmed
- EAACI Allergen Immunotherapy User's Guide. (2020) pubmed
- The Efficacy of Sublingual Immunotherapy in Patients With House Dust Mite Allergic Asthma-A Systematic Review. (2025) pubmed
- Mite immunotherapy. (2006) pubmed
- Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms. (2023) pubmed